GENEDX HOLDINGS (WGS)
(Real Time Quote from BATS)
$31.65 USD
-0.83 (-2.56%)
Updated Aug 30, 2024 12:44 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
WGS 31.65 -0.83(-2.56%)
Will WGS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for WGS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for WGS
Best Momentum Stocks to Buy for August 5th
How Much Upside is Left in GENEDX HOLDINGS (WGS)? Wall Street Analysts Think 40.34%
WGS: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for August 5th
GeneDx Holdings Corp. (WGS) Reports Q2 Loss, Tops Revenue Estimates
Best Momentum Stocks to Buy for July 23rd
Other News for WGS
Wells Fargo initiates GeneDx with an Equal Weight, $34 price target
Not Enough To Keep OPKO Health Flying
GeneDx initiated with neutral view at Wells Fargo
GeneDx Holdings: Profits On The Horizon For AI Driven Health Platform
GeneDx to Participate in Fall Investor Conferences